| 2025-05-09 |
13D/A |
IVA / Inventiva S.A. - Depositary Receipt (Common Stock) |
Biotechnology Value Fund L P |
8,545,499 |
6.10 |
0.00 |
| 2025-05-08 |
13D/A |
INAB / IN8bio, Inc. |
BIOS Fund II, LP |
9,120,073 |
9.99 |
-12.44 |
| 2025-05-08 |
13D/A |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,390,964 |
13.27 |
0.00 |
| 2025-05-08 |
13D |
YCBD / cbdMD, Inc. |
Porter Jeffrey H |
573,530 |
6.40 |
|
| 2025-05-08 |
13D/A |
SLNCF / Silence Therapeutics plc |
Griffiths Richard Ian |
32,912,599 |
23.20 |
6.40 |
| 2025-05-07 |
13D/A |
IVA / Inventiva S.A. - Depositary Receipt (Common Stock) |
New Enterprise Associates 17, L.P. |
8,350,730 |
6.00 |
6.57 |
| 2025-05-06 |
13D/A |
PRTA / Prothena Corporation plc |
EcoR1 Capital, LLC |
5,304,596 |
9.90 |
-54.21 |
| 2025-05-06 |
13D/A |
IRD / Opus Genetics, Inc. |
Foundation Fighting Blindness Retinal Degeneration Fund |
9,492,171 |
15.90 |
270.10 |
| 2025-05-02 |
13D/A |
RPRX / Royalty Pharma plc |
Severgnini Achille G. |
29,926,170 |
6.90 |
-16.88 |
| 2025-05-02 |
13D |
HLVX / HilleVax, Inc. |
Tang Capital Management Llc |
4,920,000 |
9.80 |
|
| 2025-05-01 |
13D/A |
CRVS / Corvus Pharmaceuticals, Inc. |
Orbimed Advisors Llc |
9,785,423 |
13.80 |
40.93 |
| 2025-04-30 |
13D/A |
SLGL / Sol-Gel Technologies Ltd. |
Arkin Moshe |
18,449,907 |
61.79 |
|
| 2025-04-28 |
13D/A |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,390,964 |
13.29 |
0.00 |
| 2025-04-28 |
13D |
PROCF / Procaps Group S.A. |
Becaril S.A. |
1,304,518,234 |
53.00 |
|
| 2025-04-25 |
13D/A |
PASG / Passage Bio, Inc. |
Orbimed Advisors Llc |
6,650,000 |
10.70 |
-10.19 |
| 2025-04-25 |
13D |
PROCF / Procaps Group S.A. |
Chemo Project, S.A. |
1,304,518,234 |
53.00 |
|
| 2025-04-25 |
13D |
CRBU / Caribou Biosciences, Inc. |
Haurwitz Rachel E. |
4,716,003 |
5.00 |
7.70 |
| 2025-04-24 |
13D/A |
PBLA / Panbela Therapeutics, Inc. |
Nant Capital, LLC |
32,432,432 |
86.98 |
1,236.28 |
| 2025-04-24 |
13D/A |
SLNCF / Silence Therapeutics plc |
Griffiths Richard Ian |
30,933,897 |
21.80 |
5.63 |
| 2025-04-24 |
13D |
EPIX / ESSA Pharma Inc. |
BML Investment Partners, L.P. |
4,221,546 |
9.50 |
0.00 |
| 2025-04-23 |
13D/A |
EPIX / ESSA Pharma Inc. |
Soleus Capital Master Fund, L.P. |
2,262,026 |
5.10 |
0.00 |
| 2025-04-23 |
13D/A |
UAN / CVR Partners, LP - Limited Partnership |
Icahn Enterprises Holdings L.p. |
4,164,274 |
39.40 |
|
| 2025-04-22 |
13D |
PROCF / Procaps Group S.A. |
Flying Fish Ventures, L.P. |
2,077,549,443 |
84.38 |
|
| 2025-04-22 |
13D |
PROCF / Procaps Group S.A. |
Saint Thomas Commercial S.A. |
2,077,549,443 |
84.38 |
|
| 2025-04-21 |
13D/A |
IMVT / Immunovant, Inc. |
Roivant Sciences Ltd. |
96,660,341 |
56.90 |
0.00 |
| 2025-04-18 |
13D/A |
NCNA / NuCana plc - Depositary Receipt (Common Stock) |
Carlyle Group Inc. |
3,430,062 |
2.40 |
2.29 |
| 2025-04-18 |
13D/A |
KROS / Keros Therapeutics, Inc. |
Pontifax Management 4 G.p. (2015) Ltd. |
4,787,331 |
11.80 |
1.12 |
| 2025-04-17 |
13D/A |
AVIR / Atea Pharmaceuticals, Inc. |
Radoff Family Foundation |
3,380,100 |
4.00 |
8.86 |
| 2025-04-16 |
13D/A |
PROCF / Procaps Group S.A. |
Hoche Partners Pharma Holding S.A. |
2,077,549,443 |
84.38 |
1,682.62 |
| 2025-04-15 |
13D/A |
GPRE / Green Plains Inc. |
Ancora Alternatives LLC |
4,340,575 |
6.70 |
10.48 |
| 2025-04-15 |
13D |
EPIX / ESSA Pharma Inc. |
Soleus Capital Master Fund, L.P. |
2,262,026 |
5.10 |
|
| 2025-04-14 |
13D/A |
RENB / Lunai Bioworks Inc. |
William Anderson Wittekind |
18,133,196 |
10.40 |
-1.89 |
| 2025-04-11 |
13D |
AIMD / Ainos, Inc. |
Ting Chuan Lee |
1,431,432 |
7.20 |
|
| 2025-04-11 |
13D |
AIMD / Ainos, Inc. |
Chun-Hsien Tsai |
1,651,862 |
8.31 |
|
| 2025-04-11 |
13D |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,390,964 |
13.29 |
|
| 2025-04-11 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Orbimed Advisors Llc |
15,219,994 |
11.00 |
-19.01 |
| 2025-04-10 |
13D/A |
MTNB / Matinas BioPharma Holdings, Inc. |
Sanitam Partners LLC |
17,104,899 |
9.99 |
1,293.39 |
| 2025-04-10 |
13D/A |
MTNB / Matinas BioPharma Holdings, Inc. |
Pembroke & Partners LLC |
16,895,712 |
9.99 |
1,559.06 |
| 2025-04-09 |
13D/A |
LIPO / Lipella Pharmaceuticals Inc. |
Kaufman Jonathan H |
212,290 |
4.90 |
0.00 |
| 2025-04-09 |
13D/A |
LIPO / Lipella Pharmaceuticals Inc. |
Chancellor Michael B |
209,641 |
4.80 |
0.00 |
| 2025-04-09 |
13D/A |
AIMD / Ainos, Inc. |
Ainos Inc |
2,456,319 |
10.68 |
0.00 |
| 2025-04-09 |
13D |
EPIX / ESSA Pharma Inc. |
Biotechnology Value Fund L P |
8,748,629 |
19.70 |
0.00 |
| 2025-04-08 |
13D/A |
ZYME / Zymeworks Inc. |
EcoR1 Capital, LLC |
17,699,774 |
25.40 |
4.99 |
| 2025-04-08 |
13D/A |
KARX / Karbon-X Corp. |
Morsevo Trading, Inc. |
6,925,550 |
8.50 |
55.21 |
| 2025-04-07 |
13D/A |
HROW / Harrow, Inc. |
Baum Mark L |
4,056,962 |
10.69 |
16.30 |
| 2025-04-07 |
13D/A |
DRMA / Dermata Therapeutics, Inc. |
Proehl Gerald T |
804,098 |
13.30 |
245.06 |
| 2025-04-07 |
13D/A |
LIPO / Lipella Pharmaceuticals Inc. |
Kaufman Jonathan H |
212,290 |
8.00 |
0.00 |
| 2025-04-07 |
13D |
BHC / Bausch Health Companies Inc. |
Meruelo Alex |
36,761,788 |
9.99 |
|
| 2025-04-07 |
13D/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
17,455,376 |
12.20 |
144.07 |
| 2025-04-04 |
13D/A |
ERNA / Ernexa Therapeutics Inc. |
Cherington Charles |
20,432,634 |
32.80 |
22.78 |
